Clinical Trial Update: Effects Of Oral Prednisolone On Bone Metabolism In Patients With Chronic Obstructive Pulmonary Disease [Phase 1]

View source ↗

Summary

Phase 1 trial investigating how oral prednisolone affects bone metabolism in patients with chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Prednisolone (Prednisolone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED